Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Change in Inventory (2024 - 2025)

Outlook Therapeutics (OTLK) has disclosed Change in Inventory for 2 consecutive years, with $119660.0 as the latest value for Q4 2025.

  • On a quarterly basis, Change in Inventory fell 96.15% to $119660.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $348667.0, a N/A change, with the full-year FY2025 number at $3.3 million, changed N/A from a year prior.
  • Change in Inventory was $119660.0 for Q4 2025 at Outlook Therapeutics, up from -$788312.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $3.1 million in Q4 2024 to a low of -$788312.0 in Q3 2025.